1. Home
  2. AVXL vs HMH Comparison

AVXL vs HMH Comparison

Compare AVXL & HMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$1.51

Market Cap

237.2M

Sector

Health Care

ML Signal

HOLD

Logo HMH Holding Inc. Class A Common Stock

HMH

HMH Holding Inc. Class A Common Stock

SELL

Current Price

$18.46

Market Cap

237.2M

ML Signal

SELL

Company Overview

Basic Information
Metric
AVXL
HMH
Founded
2004
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil and Gas Field Machinery
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
237.2M
237.2M
IPO Year
2013
2024

Fundamental Metrics

Financial Performance
Metric
AVXL
HMH
Price
$1.51
$18.46
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $28.71
AVG Volume (30 Days)
★ 1.1M
204.7K
Earning Date
11-24-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 1.26
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.81
P/E Ratio
★ N/A
$14.63
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$16.87
52 Week High
$9.50
$22.34

Technical Indicators

Market Signals
Indicator
AVXL
HMH
Relative Strength Index (RSI) 20.06 46.31
Support Level N/A $18.30
Resistance Level $2.80 $20.16
Average True Range (ATR) 0.13 0.89
MACD -0.03 0.08
Stochastic Oscillator 6.06 56.91

Price Performance

Historical Comparison
AVXL
HMH

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About HMH HMH Holding Inc. Class A Common Stock

HMH Holding Inc is a provider of offshore and onshore drilling equipment and services in the United States and Norway. Its services include sales of projects and products including drilling equipment packages for newbuild or a reactivated drilling rig, and individual or grouped components of drilling and pressure control equipment. The company also offers aftermarket services including services and replacement parts on installed equipment and integrated digital solutions. The company sells equipment and services to drilling contractors; operators, including both oil and gas E&P companies and mining companies onshore and offshore; and manufacturers, consisting of shipyards.

Share on Social Networks: